Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,000 peer-reviewed publications.
The CPRD bibliography is updated on a monthly basis (last updated 4 February 2019) and papers are listed below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
“Early detection of multiple myeloma in primary care using blood tests: a case-control study in primary care”, Br J Gen Pract, vol. 68, pp. e586-e593, 2018.
, “Effect of Cesarean Delivery on Long-term Risk of Small Bowel Obstruction”, Obstet Gynecol, vol. 131, pp. 354-359, 2018.
, “The effects of prescribing varenicline on two-year health outcomes: an observational cohort study using electronic medical records”, Addiction, vol. 113, pp. 1105-1116, 2018.
, “Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study”, Pancreatology, 2018.
, “The epidemiology of multimorbidity in primary care: a retrospective cohort study”, Br J Gen Pract, vol. 68, pp. e245-e251, 2018.
, “Estimating individualized optimal combination therapies through outcome weighted deep learning algorithms”, Stat Med, vol. 37, pp. 3869-3886, 2018.
, “Estimating the health-care costs of children born to pregnant smokers in England: cohort study using primary and secondary health-care data”, Addiction, vol. 113, pp. 1305-1316, 2018.
, “Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink”, BMJ Open, vol. 8, p. e023118, 2018.
, “Exacerbation risk and characterisation of the UK's asthma population from infants to old age”, Thorax, vol. 73, pp. 313-320, 2018.
, “Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink”, BMJ Open, vol. 8, p. e023830, 2018.
, “Exploring the Potential Routine Use of Electronic Healthcare Record Data to Strengthen Early Signal Assessment in UK Medicines Regulation: Proof-of-Concept Study”, Drug Saf, vol. 41, pp. 899-910, 2018.
, “Exposure measurement error when assessing current glucocorticoid use using UK primary care electronic prescription data”, Pharmacoepidemiol Drug Saf, 2018.
, “Exposure to domestic violence and abuse and consultations for emergency contraception: nested case-control study in a UK primary care dataset”, Br J Gen Pract, 2018.
, “External validation of ADO, DOSE, COTE and CODEX at predicting death in primary care patients with COPD using standard and machine learning approaches”, Respir Med, vol. 138, pp. 150-155, 2018.
, “Factors associated with consultation rates in general practice in England, 2013-2014: a cross-sectional study”, Br J Gen Pract, vol. 68, pp. e370-e377, 2018.
, “Factors associated with stroke, myocardial infarction, ischemic heart disease, unstable angina, or mortality in patients from real world clinical practice with newly-diagnosed type 2 diabetes and early glycemic control”, Curr Med Res Opin, vol. 34, pp. 337-343, 2018.
, “Fate of the metabolically healthy obese-is this term a misnomer? A study from the Clinical Practice Research Datalink”, Int J Obes (Lond), 2018.
, “Gastrointestinal bleeding risk of selective serotonin reuptake inhibitors by level of kidney function: A population-based cohort study”, Br J Clin Pharmacol, vol. 84, pp. 2142-2151, 2018.
, “Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK”, Cancer Epidemiol, vol. 54, pp. 104-111, 2018.
, “Generalizing Randomized Clinical Trial Results: Implementation and Challenges Related to Missing Data in the Target Population”, Am J Epidemiol, vol. 187, pp. 817-827, 2018.
,